CANCER BIO-IMMUNOTHERAPY CONTINUED
Its effect on inductional control, triggered by hormones and mediated by transformed mitochondria
by Thomas Tallberg
Synopsis of presentations at the 3rd. World Congress on Cancer
Darwin 25-27th, April 1997
Active specific immunotherapy with supportive measures in the treatment of palliatively nephrectomized, renal adenocarcinoma patients. A thirteen-year follow-up study.
Tallberg T, Tykkä H, Mahlberg K, Halttunen P, Lehtonen T, Kalima T, Sarna S.
Eur Urol. 1985;11(4):233-43.
PMID: 2412827
Macroscopical and histopathological changes in regressing primary and recurrent equine sarcoids during active specific bio-immunotherapy.
Hallamaa RE, Saario E, Tallberg T.
In Vivo. 2005 Jul-Aug;19(4):761-7.
PMID: 15999546
Ultrastructural changes in regressing equine sarcoid tumours--mysterious role of mitochondria.
Hallamaa RE.
In Vivo. 2008 Jul-Aug;22(4):519-23.
PMID: 18712182
Bio-immunotherapy in the treatment of equine sarcoid, the commonest tumour of the horse
Research Article
Raija E. Hallamaa
Veterinary Clinic, Pisteenkaari 4, 03100 Nummela
Institute of Bio-Immunotherapy, Gylden Str. 2B, 00200 Helsinki, Finland
Active specific immunotherapy with supportive measures in the treatment of advanced palliatively nephrectomised renal adenocarcinoma. A controlled clinical study.
Tykkä H.
Scand J Urol Nephrol Suppl. 1981;63:1-107.
PMID: 6184775
Postoperative active specific immunotherapy with supportive measures in patients suffering from recurrent metastasized melanoma: case reports of six patients.\nTallberg T, Kalima T, Halttunen P, Tykkä H, Mahlberg K, Matous B, Sundell B.\nJ Surg Oncol. 1986 Oct;33(2):115-9.\nPMID: 3762183